Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2015 1
2016 1
2017 1
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Role of surgery in high-grade neuroendocrine tumors of the lung.
Bedirhan MA, Ürer N, Seyrek Y, Arda N, Fener N, Cansever L, Kıyık M, Altın S. Bedirhan MA, et al. Among authors: kiyik m. Turk Gogus Kalp Damar Cerrahisi Derg. 2022 Jul 29;30(3):389-394. doi: 10.5606/tgkdc.dergisi.2022.19700. eCollection 2022 Jul. Turk Gogus Kalp Damar Cerrahisi Derg. 2022. PMID: 36303705 Free PMC article.
Economic burden of lung cancer in Turkey: a cost of illness study from payer perspective.
Cicin I, Oksuz E, Karadurmus N, Malhan S, Gumus M, Yilmaz U, Cansever L, Cinarka H, Cetinkaya E, Kiyik M, Ozet A; Lung Cancer Report Study Group Turkey; Turkish Society of Lung Cancer; Lung Health and Intensive Care Association; University of Health Sciences; Turkish Society of Medical Oncology; National Cancer Institute; Turkish Respiratory Society. Cicin I, et al. Among authors: kiyik m. Health Econ Rev. 2021 Jun 26;11(1):22. doi: 10.1186/s13561-021-00322-2. Health Econ Rev. 2021. PMID: 34173876 Free PMC article.
An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer.
Novello S, Scagliotti G, de Castro G Jr, Kiyik M, Kowalyszyn R, Deppermann KM, Arriola E, Bosquee L, Novosiadly RD, Nguyen TS, Forest A, Tang S, Kambhampati SRP, Cosaert J, Reck M. Novello S, et al. Among authors: kiyik m. J Thorac Oncol. 2017 Feb;12(2):383-389. doi: 10.1016/j.jtho.2016.07.013. Epub 2016 Jul 25. J Thorac Oncol. 2017. PMID: 27464970 Free article. Clinical Trial.
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial.
Soria JC, Felip E, Cobo M, Lu S, Syrigos K, Lee KH, Göker E, Georgoulias V, Li W, Isla D, Guclu SZ, Morabito A, Min YJ, Ardizzoni A, Gadgeel SM, Wang B, Chand VK, Goss GD; LUX-Lung 8 Investigators. Soria JC, et al. Lancet Oncol. 2015 Aug;16(8):897-907. doi: 10.1016/S1470-2045(15)00006-6. Epub 2015 Jul 5. Lancet Oncol. 2015. PMID: 26156651 Clinical Trial.
A prospective, multicentre clinical trial comparing cisplatin plus gemcitabine with cisplatin plus etoposide in patients with locally advanced and metastatic non-small cell lung cancer.
Goksel T, Hatipoglu ON, Ozturk C, Gorguner M, Kiyik M, Yilmaz U, Guzelant A, Tasbakan S, Tabakoglu E, Firat H, Tutar U, Cikrikicioglu S, Akkoclu A, Soyer S, Cakir E, Itil O, Sanal S. Goksel T, et al. Among authors: kiyik m. Respirology. 2005 Sep;10(4):456-63. doi: 10.1111/j.1440-1843.2005.00739.x. Respirology. 2005. PMID: 16135168 Clinical Trial.